← Back
Data updated: Mar 10, 2026
PIERRE FABRE
OncologyImmunologyGastroenterology
PIERRE FABRE is a specialty pharmaceutical company focused on Oncology, Immunology, Gastroenterology.
1994
Since
2
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 90%
1 drugs Phase 3: 1 Phase 2: 4 Phase 1: 9
Immunology 7%
0 drugs Phase 2: 1
Gastroenterology 3%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Immunology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology, Immunology